PDT Partners’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
Other funds holding CTKB
PDT Partners's CTKB Position: Q3 2026 in Review
PDT Partners increased its Cytek Biosciences (CTKB) stake by 45% in Q3 2026, buying an estimated $184K and bringing the position to 125,587 shares worth $748K. The position accounts for 0.04% of the portfolio, ranked #366.
PDT Partners first reported a position in CTKB in Q1 2022 and has held it in 13 quarters since. The position peaked at $987K in Q2 2023. 150 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.
- PDT Partners held 125,587 shares of Cytek Biosciences worth $748K as of Q3 2026.
- PDT Partners bought 38,718 Cytek Biosciences shares in Q3 2026, an estimated $184K.
- Cytek Biosciences made up 0.04% of PDT Partners's portfolio in Q3 2026, its #366 holding.
- PDT Partners first reported a position in Cytek Biosciences in Q1 2022 and has held it in 13 quarters since.
- PDT Partners's Cytek Biosciences position peaked at $987K in Q2 2023.
- 150 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.
Based on PDT Partners's 13F filing for Q3 2026, filed 16 Nov 2026.